Ensuring Recruitment and Compliance Success of an Evolving Rare Neuromuscular Disease Study
A biotechnology company was planning a global Phase III and eventual expansion study of a rare neuromuscular disease over the course of three years. The trial’s success required a strategic combination of resources to both research sites and participants. The study team selected the Longboat Platform to:
- Provide training for every staff member at every trial site
- Update trial resources and guidance after multiple protocol amendments
- Create and deploy recruitment and engagement resources, ensuring participants and caregivers were engaged and supported during their trial experience
Download the case study to find out how the Longboat Platform ensured not only recruitment success, but site and participant support and compliance.
Who Should Watch?
Certificate of Attendance
Time: 1 p.m. ET, 12 p.m. CT, 10 a.m. PT
Duration: 1 hour